PROTHENA CORPORATION PUBLIC LIMITED COMPANY Shares Issued
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) had Shares Issued of 51.74 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-06
- 2026-06-30: Common Stock, Shares, Issued 51.74M shares.
- 2026-03-31: Common Stock, Shares, Issued 53.08M shares.
- 2025-12-31: Common Stock, Shares, Issued 53.83M shares.
- 2025-09-30: Common Stock, Shares, Issued 53.83M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 51.74M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 53.08M shares 10-Q · filed 2026-05-07 | |
| 2025-12-31 | 53.83M shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | 53.83M shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 53.83M shares 10-Q · filed 2025-08-04 | |
| 2025-03-31 | 53.83M shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 53.83M shares 10-K · filed 2026-02-27 | |
| 2024-09-30 | 53.81M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 53.77M shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 53.72M shares 10-Q · filed 2024-05-08 | |
| 2023-12-31 | 53.68M shares 10-K · filed 2025-02-27 | |
| 2023-09-30 | 53.64M shares 10-Q · filed 2023-11-02 | |
| 2023-06-30 | 53.49M shares 10-Q · filed 2023-08-03 | |
| 2023-03-31 | 52.68M shares 10-Q · filed 2023-05-04 | |
| 2022-12-31 | 52.10M shares 10-K · filed 2024-02-22 | |
| 2022-09-30 | 47.89M shares 10-Q · filed 2022-11-03 | |
| 2022-06-30 | 46.81M shares 10-Q · filed 2022-08-08 | |
| 2022-03-31 | 46.75M shares 10-Q · filed 2022-05-05 | |
| 2021-12-31 | 46.66M shares 10-K · filed 2023-02-28 | |
| 2021-09-30 | 46.53M shares 10-Q · filed 2021-11-04 | |
| 2021-06-30 | 44.91M shares 10-Q · filed 2021-08-05 | |
| 2021-03-31 | 44.18M shares 10-Q · filed 2021-05-11 | |
| 2020-12-31 | 39.92M shares 10-K · filed 2022-02-25 | |
| 2020-09-30 | 39.92M shares 10-Q · filed 2020-11-04 | |
| 2020-06-30 | 39.91M shares 10-Q · filed 2020-08-06 | |
| 2020-03-31 | 39.91M shares 10-Q · filed 2020-05-06 | |
| 2019-12-31 | 39.90M shares 10-K · filed 2021-02-26 | |
| 2019-09-30 | 39.90M shares 10-Q · filed 2019-11-05 | |
| 2019-06-30 | 39.90M shares 10-Q · filed 2019-08-06 | |
| 2019-03-31 | 39.86M shares 10-Q · filed 2019-05-07 | |
| 2018-12-31 | 39.86M shares 10-K · filed 2020-03-03 | |
| 2018-09-30 | 39.86M shares 10-Q · filed 2018-11-06 | |
| 2018-06-30 | 39.83M shares 10-Q · filed 2018-08-07 | |
| 2018-03-31 | 39.82M shares 10-Q · filed 2018-05-09 | |
| 2017-12-31 | 38.48M shares 10-K · filed 2019-03-15 | |
| 2017-09-30 | 38.44M shares 10-Q · filed 2017-11-07 | |
| 2017-06-30 | 38.16M shares 10-Q · filed 2017-08-09 | |
| 2017-03-31 | 37.96M shares 10-Q · filed 2017-05-09 | |
| 2016-12-31 | 34.75M shares 10-K · filed 2018-02-26 | |
| 2016-09-30 | 34.46M shares 10-Q · filed 2016-11-02 | |
| 2016-06-30 | 34.38M shares 10-Q · filed 2016-08-02 | |
| 2016-03-31 | 34.34M shares 10-Q · filed 2016-05-04 | |
| 2015-12-31 | 31.74M shares 10-K · filed 2017-02-27 | |
| 2015-09-30 | 31.52M shares 10-Q · filed 2015-11-02 | |
| 2015-06-30 | 31.38M shares 10-Q · filed 2015-08-05 | |
| 2015-03-31 | 27.47M shares 10-Q · filed 2015-05-06 | |
| 2014-12-31 | 27.39M shares 10-K · filed 2016-02-25 | |
| 2014-09-30 | 27.38M shares 10-Q · filed 2014-11-04 | |
| 2014-06-30 | 26.66M shares 10-Q · filed 2014-08-05 | |
| 2014-03-31 | 21.90M shares 10-Q · filed 2014-05-05 | |
| 2013-12-31 | 21.86M shares 10-K · filed 2015-03-13 | |
| 2013-09-30 | 17.68M shares 10-Q · filed 2013-11-12 | |
| 2013-06-30 | 17.68B shares 10-Q · filed 2013-08-13 | |
| 2013-03-31 | 17.68M shares 10-Q · filed 2013-05-15 | |
| 2012-12-31 | 17.68M shares 10-K · filed 2014-03-07 | 17.68M shares 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |